No Vaccine in Sight
The events of recent months, says a growing alliance of public health experts and industry reform advocates, have further exposed the faults of the current model and bolstered the case for alternatives.Featured Publications
Chevron deference is running on fumes
CFPB Credit Card Late Fee Goes into Effect
Market Gateways, Not the EPA, Determine Power Sector Decarbonization
Artificial Intelligence Legislative Outlook: Spring 2024 Update